Grade My Investments

GeneDx Holdings Corp. (WGS) Stock Grade

WGS · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$3.5B
P/E Ratio
Revenue Growth (YoY)
+40.0%
Net Margin
-4.9%
Return on Equity
Dividend Yield
None

About GeneDx Holdings Corp.'s fundamentals

GeneDx Holdings is a healthcare information services company with a $3.5B market capitalization that is experiencing strong revenue expansion, growing 40% year-over-year. Despite this growth, the company currently operates at a net loss with a negative 4.9% net margin, indicating it is not yet profitable on an accounting basis. However, the company is generating positive free cash flow, suggesting its underlying operations are converting sales into cash despite the reported accounting losses. The company does not pay a dividend.

Track WGS free — no credit card required. Live grade + monthly AI report →